Apoptosis: Live Or Die - Hard Work Either Way!

 

 Buy Article Permissions and Reprints

This review presents a brief overview of the cell's apoptotic machinery, including specific and indirect death signals. Specific death signals are transferred via death ligands, death receptors, and their intracellular signalling pathways. Indirect death signals cumulate a wide range of stimuli that potentially harm survival of cells. These include intercalating drugs, irradiation or altered intracellular signalling. Herein, a focal point is the mitochondrial control of specific death enzymes - so called caspases - by members of the pro-apoptotic Bax and BH3 subfamily or the anti-apoptotic Bcl-2 subfamily. While the initiation of cell death happens through a variety of signalling systems, the activation of caspases plays a pivotal role in the progression towards the final morphologic findings in cells undergoing apoptosis. Caspases appear to directly cleave and inactivate substrates that are clinical for the maintenance of cell structure and function but also regulate the activity of other enzymes that induce the apoptotic phenotype within the cell. The insulin-like growth factors (IGFs) are potent proliferation factors and potently inhibit apoptosis acting via the ubiquitously expressed IGF-I receptor. Within IGF-I receptor signalling, key to the inhibition of apoptosis are the RAS/RAF/mitogen-activated protein (MAP)-kinase pathway and the PI 3'-kinase pathway. To give an example of high clinical relevance of apoptosis within endocrine disorders, apoptotic death of pancreatic beta cells in type 1 diabetes disease and the involvement of IGF-II in beta cell survival and beta cell function is discussed in detail. Finally, further understanding of signalling systems that are involved in proliferation or in apoptosis might provide novel tools to treat or even haeal disorders like type I diabetes.

 References

• 1 Kiess W, Gallaher B W. Hormonal control of programmed cell death/apoptosis.  Eur J Endocrinol. 1998;  138 482-491
  CrossrefPubMedGoogle Scholar
• 2 Ashkenazi A, Dixit V M. Death receptors: signalling and modulation.  Science. 1998;  281 1305-1308.
  CrossrefPubMedGoogle Scholar
• 3 Marsters S A, Sheridan J P, Pitti R M, Brush J, Goddard A, Ashkenazi A. Identification of a ligand for the death-domain-containing receptor Apo3.  Curr Biol. 1998;  8 525-528
  CrossrefPubMedGoogle Scholar
• 4 Marsters S A, Pitti R A, Sheridan J P, Ashkenazi A. Control of apoptosis signalling by Apo2 ligand.  Rec Prog Horm Res. 1999;  54 225-234
  PubMedGoogle Scholar
• 5 Medema J P, de Jong J, van Hall T, Melief C J, Offringa R. Immune escape of tumours in vivo by expression of cellular FLICE-inhibitory protein.  J Exp Med. 1999;  190 1033-1038
  CrossrefPubMedGoogle Scholar
• 6 Chang H Y, Nishitoh H, Yang X, Ichijo H, Baltimore D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adaptor protein Daxx.  Science. 1998;  281 1860-1863
  CrossrefPubMedGoogle Scholar
• 7 Hofmann K. The modular nature of apoptotic signalling proteins.  Cell Mol Life Sci. 1999;  55 1113-1128
  CrossrefPubMedGoogle Scholar
• 8 Wang C Y, Mayo M W, Komeluk R G, Goeddel D V, Baldwin A S Jr. NF-kappa B antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.  Science. 1998;  281 1680-1683
  CrossrefPubMedGoogle Scholar
• 9 Deveraux O L, Roy N, Stennicke H R, Van Arsdale T, Zhou Q, Srinivasula S M, Alnemri E S, Salvesen G S, Reed J C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.  EMBO J. 1998;  17 2215-2223
  CrossrefPubMedGoogle Scholar
• 10 Jones J L, Walker R A. Integrins: a role as cell signalling molecules.  Mol Pathol. 1999;  52 208-213
  PubMedGoogle Scholar
• 11 Smets L A, Salomons G, van den Berg J. Glucocorticoid induced apoptosis in leukaemia.  Adv Exp Med Biol. 1999;  457 607-614
  PubMedGoogle Scholar
• 12 Mui A L. The role of STATs in proliferation, differentiation, and apoptosis.  Cell Mol Life Sci. 1999;  55 1547-1558
  CrossrefPubMedGoogle Scholar
• 13 Zhivotovsky B, Joseph B, Orrenius S. Tumor radiosensitivity and apoptosis.  Exp Cell Res. 1999;  248 10-17
  CrossrefPubMedGoogle Scholar
• 14 Nitiss J L, Beck W T. Antitopoisomerase drug action and resistance.  Eur J Cancer. 1996;  32A 958-966
  PubMedGoogle Scholar
• 15 Evan G, Littlewood T. A matter of life and cell death.  Science. 1998;  281 1317-1322
  CrossrefPubMedGoogle Scholar
• 16 Xiang H, Kinoshita Y, Knudson C M, Korsmeyer S J, Schwartzkroin P A, Morrison R S. Bax involvement in p53-mediated neuronal cell death.  J Neurosci. 1998;  18 1363-1373.
  PubMedGoogle Scholar
• 17 Kannan K, Amariglio N, Rechavi G, Givol D. Profile of gene expression regulated by induced p53: connection to the TGF-beta family.  FEBS Lett. 2000;  470 77-82
  CrossrefPubMedGoogle Scholar
• 18 Green D R, Reed J C. Mitochondria and apoptosis.  Science. 1988;  281 1309-1312
  PubMedGoogle Scholar
• 19 Minn A J, Velez P, Schendel S L, Liang H, Muchmore S W, Fesik S W, Fill M, Thompson C B. Bcl-x(L) forms an ion channel in synthetic lipid membranes.  Nature. 1997;  385 353-357
  CrossrefPubMedGoogle Scholar
• 20 Matsuyama S, Xu Q, Velopurs J, Reed J C. The mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells.  Mol Cell. 1998;  1 327-336
  CrossrefPubMedGoogle Scholar
• 21 Jurgensmeier J M, Krajewski S, Armstrong R C, Wilson G M, Oltersdorf T, Fritz L C, Reed J C, Ottilie S. Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe.  Mol Biol Cell. 1997;  8 325-339
  PubMedGoogle Scholar
• 22 Hu Y, Benedict M A, Ding L, Nunez G. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis.  EMBO J. 1999;  18 3586-3595
  CrossrefPubMedGoogle Scholar
• 23 Adams J M, Cory S. The Bcl-2 protein family: arbiters of cell survival.  Science. 1998;  281 1322-1326
  CrossrefPubMedGoogle Scholar
• 24 Yamamoto K, Ichijo H, Korsmeyer S J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.  Mol Cell Biol. 1999;  19 8469-8478
  PubMedGoogle Scholar
• 25 Kulik G, Weber M. Akt-dependent and -independent survival signalling pathways utilized by insulin-like growth factor I.  Mol Cell Biol. 1998;  18 6711-6718
  PubMedGoogle Scholar
• 26 Cohen G M. Caspases: the executioners of apoptosis.  Biochem J. 1997;  326 1-16
  PubMedGoogle Scholar
• 27 Wang I K, Lin-Shiau S Y, Lin J K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells.  Eur J Cancer. 1999;  35 1517-1525
  CrossrefPubMedGoogle Scholar
• 28 Talanian R V, Yang X, Turbov J, Seth P, Ghayur T, Casiano C A, Orth K, Froelich C J. Granule-mediated killing: pathways for granzyme B-initiated apoptosis.  J Exp Med. 1997;  186 1323-1331
  CrossrefPubMedGoogle Scholar
• 29 Zheng T S, Schlosser S F, Dao T, Hingorani R, Crispe I N, Boyer J L, Flavell R A. Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo.  Proc Natl Acad Sci. 1998;  95 13 618-13 623
  PubMedGoogle Scholar
• 30 Janicke R U, Ng P, Sprengart M L, Porter A G. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis.  J Biol Chem. 1998;  273 15 540-15 545
  PubMedGoogle Scholar
• 31 Buendia B, Santa-Maria A, Courvalin J C. Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis.  J Cell Sci. 1999;  112 1743-1753
  PubMedGoogle Scholar
• 32 McCarty J S, Toh S Y, Li P. Multiple domains of DFF45 bind synergistically to DFF40: roles of caspase cleavage and sequestration of activator domain of DFF40.  Biochem Biophys Res Commun. 1999;  264 181-185
  CrossrefPubMedGoogle Scholar
• 33 Geng Y J, Azuma T, Tang J X, Hartwig J H, Muszynski M, Wu O, Libby P, Kwiatkowski D J. Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines.  Eur J Cell Biol. 1998;  77 294-302
  PubMedGoogle Scholar
• 34 Sgorbissa A, Benetti R, Marzinotto S, Schneider C, Brancolini C. Caspase-3 and caspase-7 but not caspase-6 cleave Gas2 in vitro: implications for microfilament reorganization during apoptosis.  J Cell Sci. 1999;  112 4475-4482
  PubMedGoogle Scholar
• 35 Chen O, Gong B, Almasan A. Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis.  Cell Death Differ. 2000;  7 227-233
  CrossrefPubMedGoogle Scholar
• 36 Susin S A, Lorenzo H K, Zamzami N, Marzo I, Snow B E, Brothers G M, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett D R, Aebersold R, Siderovski D P, Penninger J M, Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor.  Nature. 1999;  397 441-446
  CrossrefPubMedGoogle Scholar
• 37 Herzlieb N, Gallaher B W, Berthold A, Hille R, Kiess W. IGF-I inhibits the progression of human U-2 OS osteosarcoma cells towards pcd through interaction with the IGF-I receptor.  Cell Mol Biol. 2000;  46 71-77
  PubMedGoogle Scholar
• 38 Yang B C, Chang H M, Wang Y S, Chen R F, Lin S J. Transient induction of apoptosis in serum-starved glioma cells by insulin and IGF-I.  Biochem Biophys Acta. 1996;  1314 83-92
  PubMedGoogle Scholar
• 39 Ciesielski M J, Fenstermaker R A. Synergistic cytotoxicity, apoptosis and protein-linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorylation.  J Neurooncol. 1999;  41 223-234
  CrossrefPubMedGoogle Scholar
• 40 Valentinis B, Morrione A, Peruzzi F, Prisco M, Reiss K, Baserga R. Anti-apoptotic signalling of the IGF-I receptor in fibroblasts following loss of matrix adhesion.  Oncogene. 1999;  18 1827-1836
  CrossrefPubMedGoogle Scholar
• 41 Valentinis B, Reiss K, Baserga R. Insulin-like growth factor-I-mediated survival from anoikis: role of cell aggregation and focal adhesion kinase.  J Cell Physiol. 1998;  176 648-657
  CrossrefPubMedGoogle Scholar
• 42 Le Roith D, Parrizas M, Blakesley V A. The insulin-like growth factor-I receptor and apoptosis.  Endocrine. 1997;  7 103-105
  PubMedGoogle Scholar
• 43 LeRoith D, Werner H, Beitner-Johnson D, Roberts C T. Molecular and cellular aspects of the insulin-like growth factor I receptor.  Jr Endo Rev. 1995;  16 43-163
  PubMedGoogle Scholar
• 44 Alessi D R, Cuenda A, Cohen P, Dudley D T, Saltiel A R. PD 098 059 is a specific inhibitor of the activation of mitogen-activated protein kinase. Kinase in vitro and in vivo.  J Biol Chem. 1995;  270 27 489-27 494
  PubMedGoogle Scholar
• 45 Dudley D T, Pang L, Decker S J, Bridges A J, Saltiel A R. A synthetic inhibitor of the mitogen-activated protein kinase cascade.  Proc Natl Acad Sci USA. 1995;  92 7686-7689
  CrossrefPubMedGoogle Scholar
• 46 Párrizas M, Saltiel A, LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3’-kinase and mitogen-activated protein kinase pathways.  J Biol Chem. 1997;  272 154-161
  CrossrefPubMedGoogle Scholar
• 47 Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G, Fry M J, Yonezawa K, Kasuga M, Waterfield D. PI 3-kinase: structural and functional analysis of intersubunit interactions.  EMBO J. 1994;  13 511-521
  PubMedGoogle Scholar
• 48 Vlahos C J, Matter W F, Hui K Y, Brown R F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).  J Biol Chem. 1994;  269 5241-5248
  PubMedGoogle Scholar
• 49 Kulik G, Klippel A, Weber M J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.  Mol Cell Biol. 1997;  17 1595-1606
  PubMedGoogle Scholar
• 50 Dudek H, Datta S R, Franke T F, Birnbaum M J, Yao R, Cooper G M, Segal R A, Kaplan D R, Greenberg M G. Regulation of neuronal survival by the serine-threonine protein kinase Akt.  Science. 1997;  275 661-664
  CrossrefPubMedGoogle Scholar
• 51 Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism.  J Biol Chem. 1997;  272 12 181-12 188
  PubMedGoogle Scholar
• 52 Williams A C, Collard T J, Perks C M, Newcomb P, Moorghen M, Holly J M, Paraskeva C. Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells.  Cancer REs. 2000;  60 22-27
  PubMedGoogle Scholar
• 53 Remacle-Bonnet M M, Garrouste F L, Heller S, Andre F, Marvaldi J L, Pommier G J. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signalling pathways,.  Cancer Res. 2000;  60 2007-2017
  PubMedGoogle Scholar
• 54 Kawakami A, Nakashima T, Tsuboi M, Urayama S, Matsuoka N, Ida H, Kawabe Y, Sakai H, Migita K, Aoyagi T, Nakashima M, Maeda K, Eguchi K. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts.  Biochem Biophys Res Commun. 1998;  247 46-51
  CrossrefPubMedGoogle Scholar
• 55 Kulik G, Weber M. Akt-dependent and -independent survival signalling pathways utilized by insulin-like growth factor I.  Mol Cell Biol. 1998;  18 6711-6718
  PubMedGoogle Scholar
• 56 Párrizas M, LeRoith D. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product.  Endocrinolgy. 1997;  138 1355-1358
  PubMedGoogle Scholar
• 57 Tamatani M, Ogawa S, Tohyama M. Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: a possible neuroprotective mechanism of peptide growth factors. Brain Res.  Mol Brain Res. 1998;  58 27-39
  CrossrefPubMedGoogle Scholar
• 58 Minshall C, Arkins S, Straza J, Conners J, Dantzer R, Freund G, Kelley K. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors.  J Immunol. 1997;  159 1225-1232
  PubMedGoogle Scholar
• 59 Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich K A, Boxer L M, Reusch J E. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein.  J Biol Chem. 1999;  274 27 529-27 535
  PubMedGoogle Scholar
• 60 Yoon J W, Jun H S, Santamaria P. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration of macrophages and T cells.  Autoimmunity. 1998;  27 109-122
  PubMedGoogle Scholar
• 61 Almawi W Y, Tamim H, Azar S T. T helper type 1 and 2 cytokines mediate the onset and progression of type 1 (insulin-dependent) diabetes (Clinical review).  J Clin Endocrinol Metab. 1999;  84 497-1502
  PubMedGoogle Scholar
• 62 Laffranchi R, Spinas G A. Interferon-γ inhibits insulin release and induces cell death in the pancreatic beta-cell line INS-1 independently of nitric oxide production.  Exp Cell Res. 1997;  237 217-222
  CrossrefPubMedGoogle Scholar
• 63 Loweth A C, Williams G T, James R F, Scarpello H J, Morgan N G. Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation.  Diabetes. 1998;  47 727-732
  PubMedGoogle Scholar
• 64 Stephens L A, Thomas H E, Ming L, Grell M, Darwiche R, Volodin L, Kay T WH. Tumor necrosis factor-α-mediated cell death pathways in NIT-1 insulinoma cells and primary pancreatic β-cells.  Endocrinology. 1999;  140 3219-3227
  CrossrefPubMedGoogle Scholar
• 65 Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matzusawa Y. Fas and fas ligand expression in inflamed islets in pancreas sections from patients with recent-onset type I diabetes mellitus.  Diabetologia. 1999;  42 1332-1340
  CrossrefPubMedGoogle Scholar
• 66 Hill D J, Petrik J, Arany E. Growth factors and regulation of fetal growth.  Diabetes Care. 1998;  21 60-69
  PubMedGoogle Scholar
• 67 Hill D J, Petrik J, Arany E, McDonald T J, Delovitch T L. Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non obese diabetic mice.  J Endocrinol. 1999;  161 153-165
  CrossrefPubMedGoogle Scholar
• 68 Petrik J, Arany E, McDonald T J. Hill DJ. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor-II that may act as a survival factor.  Endocrinology. 1998;  139 2994-3004
  CrossrefPubMedGoogle Scholar
• 69 Ilieva A, Yuan S, Wang R N, Agapitos D, Hill D J, Rosenberg L. Pancreatic islet cell survival following islet isolation: The role of cellular interactions in the pancreas.  J Endocrinol. 1999;  161 81-90
  PubMedGoogle Scholar
• 70 Petrik J, Pell M J, Arany E, McDonald T J, Dean W L, Reik W, Hill D J. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia.  Endocrinology. 1999;  140 2353-2363
  CrossrefPubMedGoogle Scholar
• 71 Kaino Y, Hirai H, Ito T, Kida K. Prevention of diabetes in non-obese diabetic (NOD) mice by short term and high dose IGF-1 treatment.  J Pediatr Endocrinol Metab. 1998;  11 267-272
  PubMedGoogle Scholar
• 72 Hostens K, Pavlovic D, Zambre Y, Ling Z, Van Schravendijk C, Eizirik D L, Pipeleers D G. Exposure of human islets to cytokines can result in dysproportionally elevated proinsulin release.  J Clin Invest. 1999;  104 67-72
  PubMedGoogle Scholar
• 73 Zhang Q, Tally M, Larsson O, Kennedy R T, Huang L, Hall K, Berggren P O. Insulin-like growth factor II signalling through the insulin-like growth factor II/mannose-6-phosphate receptor promotes exocytosis in insulin secreting cells.  Proc Natl Acad Sci. 1997;  94 6232-6237
  CrossrefPubMedGoogle Scholar
• 74 Fehmann H C, Jehle P, Markus U, Goke B. Functional active receptors for insulin-like growth factors-I (IGF-I) and and IGF-II on insulin-, glukagon-, and somatostatin-producing cells.  Metabolism. 1996;  45 759-766
  CrossrefPubMedGoogle Scholar
• 75 Asfari M, De W, Noel M, Holthuizen P E, Czernichow P. Insulin-like growth factor II gene expression in a rat insulin-producing beta cell line (INS-1) is regulated by glucose.  Diabetologia. 1995;  38 927-935
  PubMedGoogle Scholar
• 76 Cousin S P, Higl S R, Myers M G, White M F, Reifel-Miller A, Rhodes C J. Stimulation of pancreatic beta-cell growth by growth hormone is glucose dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.  Biochem J. 1999;  344 649-658
  CrossrefPubMedGoogle Scholar
• 77 Shapiro A M, Lakey J R, Ryan E A, Korbutt G S, Toth E, Warnock G L, Kneteman N M, Rajotte R V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.  N Engl J Med. 2000;  343 230-238
  CrossrefPubMedGoogle Scholar
• 78 Bland B J. International Pancreas Transplant Registry (ITPR) - Annual report for 1997.  ITPR News. 1998;  10 4-14
  PubMedGoogle Scholar
• 79 Bretzel R G, Brandhorst D, Brandhorst H. Improved survival of intraportal pancreatic islet cell allografts in patients with type 1 diabetes mellitus by refined peritransplant management.  J Mol Med. 1999;  77 140-143
  CrossrefPubMedGoogle Scholar
• 80 Rabinovitch A, Suerez-Pinzon W, Strynadka K, Ju Q, Edelstein D, Brownlee M, Korbutt G S, Rajotte R V. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects β-cells from cytokine-induced destruction.  Diabetes. 1999;  48 1223-1229
  PubMedGoogle Scholar
• 81 Rhodes C J. IGF-I and GH post receptor signalling mechanisms for pancreatic beta-cell replication.  J Mol Endocrinol. 2000;  24 303-311
  CrossrefPubMedGoogle Scholar
• 82 Zulewski H, Abraham E J, Gerlach M J, Daniel P B, Moritz W, Muller B, Vallejo M, Thomas M K, Habener J F. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes.  Diabetes. 2001;  50 521-533
  CrossrefPubMedGoogle Scholar

W. Kiess,M.D. 

Children’s Hospital,
University of Leipzig

Oststraße 21 - 25
04317 Leipzig
Germany


Phone: + 49 (341) 9726-000

Fax: + 49 (341) 9726-009

Email: kiw@server3.medizin.uni-leipzig.de